Zinc Citrate
Click to View Image

C12H10O14Zn3·2H2O 610.36
2-Hydroxy-1,2,3-propanetricarboxylic acid zinc salt, dihydrate     [5990-32-9].
Anhydrous     [546-46-3].
DEFINITION
Zinc Citrate contains NLT 31.3% of zinc (Zn), calculated on the dried basis.
IDENTIFICATION
•  A. Identification Tests—General, Zinc 191: A solution (1 in 10) meets the requirements.
•  B. Identification Tests—General, Citrate 191: A solution (1 in 10) meets the requirements.
ASSAY
•  Procedure
Sample:  350 mg of Zinc Citrate, previously dried at 105 for 2 h
Blank:  60 mL of water
Titrimetric system 
Mode:  Direct titration
Titrant:  0.05 M edetate disodium VS
Endpoint detection:  Visual
Analysis:  Dissolve the Sample in 60 mL of water. Add 10 mL of ammonia–ammonium chloride buffer TS and 0.1 mL of eriochrome black TS. Titrate with the Titrant to a blue endpoint. Perform a blank determination.
Calculate the percentage of zinc (Zn) in the portion of Zinc Citrate taken:
Result = [(V B) × M × F × 100]/W
V== sample titrant volume (mL)
B== blank titrant volume (mL)
M== titrant molarity (mM/mL)
F== equivalency factor, 65.4 mg/mM
W== sample weight (mg)
Acceptance criteria:  NLT 31.3% on the dried basis
IMPURITIES
•  Chloride and Sulfate, Chloride 221: A 1.0-g portion shows no more chloride than corresponds to 0.7 mL of 0.020 N hydrochloric acid (NMT 0.05%).
•  Chloride and Sulfate, Sulfate 221: A 1.8-g portion shows no more sulfate than corresponds to 0.5 mL of 0.020 N sulfuric acid (NMT 0.05%).
•  Limit of Arsenic, Cadmium, and Lead
Arsenic standard solution:  1.0 µg/mL in 1% nitric acid, prepared from an arsenic standard solution (10 mg/L)
Cadmium standard solution:  1.0 µg/mL in 1% nitric acid, prepared from a cadmium standard solution (10 mg/L)
Lead standard solution:  1.0 µg/mL in 1% nitric acid, prepared from a lead standard solution (10 mg/L)
Multi-element standard solution:  10 µg/L of lead, 5 µg/L of cadmium, and 3 µg/L of arsenic in 1% nitric acid, prepared from the Lead standard solution, Cadmium standard solution, and Arsenic standard solution, respectively
Sample solution:  2 mg/mL of Zinc Citrate in 1% nitric acid
Instrumental conditions 
Mode:  ICP-MS
Radio frequency:  1350 Watts
Nebulizer flow rate:  0.9 L/min
[Note—The radio frequency and nebulizer flow rate settings may be developed and optimized based on the manufacturer's recommendation. ]
Detection atomic masses:  As, Cd, and Pb
Blank:  1% nitric acid solution
Analysis 
Samples:  Multi-element standard solution, Sample solution, and Blank
Determine the responses of the Multi-element standard solution, Sample solution, and Blank at the masses indicated above.
Calculate the content of each element, in µg/g, in the portion of Zinc Citrate taken:
Result = (rU/rS) × (CS/CU)
rU== peak response of the corresponding element from the Sample solution
rS== peak response of the corresponding element from the Multi-element standard solution
CS== concentration of the corresponding element in the Multi-element standard solution (µg/L)
CU== concentration of Zinc Citrate in the Sample solution (g/L)
Acceptance criteria 
Arsenic:  NMT 3 µg/g
Cadmium:  NMT 5 µg/g
Lead:  NMT 10 µg/g
SPECIFIC TESTS
•  Loss on Drying 731: Dry a sample at 105 for 2 h: it loses NMT 1.0% of its weight.
•  Microbial Enumeration Tests 2021: The total aerobic microbial count does not exceed 103 cfu/g. The total combined yeasts and molds count does not exceed 102 cfu/g.
•  Microbiological Procedures for Absence of Specified Microorganisms 2022: It meets the requirements of the test for absence of Escherichia coli.
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in well-closed containers.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Huy T. Dinh, M.S.
Scientific Liaison
1-301-816-8594
(DS2010) Monographs - Dietary Supplements
2021 Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison
1-301-816-8339
(GCM2010) General Chapters - Microbiology
2022 Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison
1-301-816-8339
(GCM2010) General Chapters - Microbiology
USP35–NF30 Page 1662
Pharmacopeial Forum: Volume No. 34(2) Page 315